Functional characterization of a cancer causing mutation in human replication protein A

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Replication protein A (RPA) is crucial for eukaryotic DNA replication, repair, and recombination.
• A specific mutation (L221P) in RPA's DNA-binding site causes severe phenotypes in yeast and mice, including lethality and cancer.
• Understanding the molecular basis of this mutation is key to comprehending RPA's role in genome stability.

Purpose of the Study:

• To investigate the molecular defect caused by the L221P mutation in human RPA1.
• To analyze the functional consequences of RPA1(L221P) in cellular and in vitro systems.
• To determine the impact of this mutation on DNA replication, repair, and overall genome integrity.

Main Methods:

• Created the homologous L221P mutation in the human RPA1 gene.
• Analyzed RPA1(L221P) function in HeLa cells, assessing cell cycle progression, DNA replication, and repair.
• Evaluated the biochemical properties of the RPA1(L221P) complex in vitro, including ssDNA binding and SV40 DNA replication support.

Main Results:

• RPA1(L221P) alone prevents cell cycle progression due to defects in DNA replication and repair.
• The L221P mutation does not confer a dominant-negative effect; wild-type RPA1 rescues the phenotype.
• Recombinant RPA1(L221P) exhibits significantly reduced ssDNA binding and fails to support DNA replication in vitro, despite forming a stable complex.

Conclusions:

• The L221P mutation in human RPA1 disrupts ssDNA binding, rendering the RPA complex nonfunctional in mammals.
• Haploinsufficiency of RPA, caused by mutations like L221P, leads to increased DNA damage and cancer incidence.
• This study elucidates the molecular mechanism linking RPA dysfunction to genomic instability and oncogenesis.